EUVIMEDEUVIMED entdecken
Crossref

Microfluidic fabricated cell-laden microgels aggregated into artificial liver microtissue to ameliorate drug-induced liver injury

Fenfang Li, Tiantian Xue, Yanteng Xu, Haixia Wang, Enguo Ju, Mingqiang Li, Yu Tao

Biomaterials · 2026

DOI: 10.1016/j.biomaterials.2025.123710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials, 2026. Verfasst von Fenfang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510…. Hauptthemen laut MEDLINE: Microgels, Chemical and Drug Induced Liver Injury, Liver, Artificial, Microfluidics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Sun Yat-Sen University, Guangdong Provincial Pearl River Talents Program, Guangzhou Municipal Science and Technology Program key projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute liver failure (ALF) is a life-threatening disease for which orthotopic liver transplantation remains one of the most effective treatments. Cell therapy, particularly through the transplantation of artificial bioengineered liver grafts, emerges as a promising alternative to the whole liver transplantation in ALF management. However, the limited availability of functional human hepatocytes, the constrained techniques for swiftly creating artificial bioengineered liver grafts, and the poor cellular survival post-transplantation present significant challenges for advancing clinical applications in liver regeneration. In this study, we introduce a novel approach utilizing microfluidics to create cell-laden microgels for fabricating artificial liver microtissues, in which the controlled hepatic differentiation of stem cells and the development of liver microtissues are incorporated. The cell-laden ARGH microgels (GelMA/HAMA microgels containing AuNCs-miRNA) serving as building blocks for rapid engineering tissue construction, demonstrate the capacity for the one-step promotion of hepatic differentiation of stem cells for a short period of time. Additionally, the bioengineered liver microtissues exhibit multiple biological functionalities, including scavenging ROS, modulating inflammatory environment, and promoting angiogenesis, and can maintain long-term stability after transplantation in vivo. Furthermore, our findings reveal that the in vivo transplantation of the bioengineered liver microtissues offers therapeutic benefits in two drug-induced liver failure experimental models. The transcriptome sequencing analysis further elucidates that the microtissue transplantation ameliorated liver failure by improving liver biofunctions, reducing inflammation and oxidative stress, thereby promoting liver regeneration. Overall, this study presents an effective approach leveraging functional biomaterials and microfluidic techniques to fabricate artificial liver microtissues for liver failure treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogelsChemical and Drug Induced Liver InjuryLiver, ArtificialMicrofluidicsAnimalsHumansHepatocytesCell DifferentiationTissue EngineeringMiceLiverMaleStem CellsLiver Regeneration

Stichwörter der Autor:innen

Bioengineered microtissueCell therapyDrug-induced liver injuryMicrofluidicStem cells

Substanzen

Microgels

Autor:innen und Institutionen

  • Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
  • Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China; Key Laboratory for Polymeric Composite and Functional Mate…

Förderung

  • Sun Yat-Sen University
  • Guangdong Provincial Pearl River Talents Program
  • Guangzhou Municipal Science and Technology Program key projects
  • National Key Research and Development Program of China
  • China Primary Health Care Foundation
  • National Natural Science Foundation of China
  • Recruitment Program of Global Experts
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Li, F., Xue, T., Xu, Y., Wang, H., Ju, E., Li, M., & Tao, Y. (2026). Microfluidic fabricated cell-laden microgels aggregated into artificial liver microtissue to ameliorate drug-induced liver injury. Biomaterials. https://doi.org/10.1016/j.biomaterials.2025.123710

Vancouver

Li F, Xue T, Xu Y, Wang H, Ju E, Li M, et al. Microfluidic fabricated cell-laden microgels aggregated into artificial liver microtissue to ameliorate drug-induced liver injury. Biomaterials. 2026. doi:10.1016/j.biomaterials.2025.123710

BibTeX
@article{Li2026,
  author = {Li, Fenfang and Xue, Tiantian and Xu, Yanteng and Wang, Haixia and Ju, Enguo and Li, Mingqiang and Tao, Yu},
  title = {Microfluidic fabricated cell-laden microgels aggregated into artificial liver microtissue to ameliorate drug-induced liver injury},
  journal = {Biomaterials},
  year = {2026},
  doi = {10.1016/j.biomaterials.2025.123710}
}
Kostenlos starten →